Von Willebrand disease epidemiology and demographics: Difference between revisions
Prince Djan (talk | contribs) (→Gender) |
Prince Djan (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The prevalence of von Willebrand’s disease is 0.6 to 1.3%.<ref name="pmid18315614">{{cite journal| author=Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL et al.| title=von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). | journal=Haemophilia | year= 2008 | volume= 14 | issue= 2 | pages= 171-232 | pmid=18315614 | doi=10.1111/j.1365-2516.2007.01643.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18315614 }} </ref><ref name="pmid3492222">{{cite journal| author=Rodeghiero F, Castaman G, Dini E| title=Epidemiological investigation of the prevalence of von Willebrand's disease. | journal=Blood | year= 1987 | volume= 69 | issue= 2 | pages= 454-9 | pmid=3492222 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3492222 }} </ref> | |||
It is estimated that the referral prevalence of von Willebrand’s disease is approximately 1 case per 10,000 persons.<ref name="pmid10959685">{{cite journal| author=Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D et al.| title=Impact, diagnosis and treatment of von Willebrand disease. | journal=Thromb Haemost | year= 2000 | volume= 84 | issue= 2 | pages= 160-74 | pmid=10959685 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10959685 }} </ref> The actual abnormality (which does not necessarily lead to disease) occurs in 0.9-3% of the population. The symptoms of VWD is disproportionately more common in women of child-bearing age.<ref name="pmid18315614">{{cite journal| author=Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL et al.| title=von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). | journal=Haemophilia | year= 2008 | volume= 14 | issue= 2 | pages= 171-232 | pmid=18315614 | doi=10.1111/j.1365-2516.2007.01643.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18315614 }} </ref> Although autosomal inheritance pattern of disease lead to an equal distribution of male patients and female patients, the disease has female predominance whose bleeding tendency shows during [[menstruation]].<ref name="pmid10513768">{{cite journal| author=Lee CA| title=Women and inherited bleeding disorders: menstrual issues. | journal=Semin Hematol | year= 1999 | volume= 36 | issue= 3 Suppl 4 | pages= 21-7 | pmid=10513768 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10513768 }} </ref><ref name="pmid21040234">{{cite journal| author=Miller CH, Philipp CS, Stein SF, Kouides PA, Lukes AS, Heit JA et al.| title=The spectrum of haemostatic characteristics of women with unexplained menorrhagia. | journal=Haemophilia | year= 2011 | volume= 17 | issue= 1 | pages= e223-9 | pmid=21040234 | doi=10.1111/j.1365-2516.2010.02382.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21040234 }} </ref> There is no racial predilection to [[vWD]] however, it may be more severe or apparent in people with [[blood type]] O.<ref name="pmid3495304">{{cite journal| author=Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR| title=The effect of ABO blood group on the diagnosis of von Willebrand disease. | journal=Blood | year= 1987 | volume= 69 | issue= 6 | pages= 1691-5 | pmid=3495304 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3495304 }} </ref> | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== |
Revision as of 18:11, 14 December 2016
Von Willebrand disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Von Willebrand disease epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Von Willebrand disease epidemiology and demographics |
Von Willebrand disease epidemiology and demographics in the news |
Blogs on Von Willebrand disease epidemiology and demographics |
Risk calculators and risk factors for Von Willebrand disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prevalence of von Willebrand’s disease is 0.6 to 1.3%.[1][2] It is estimated that the referral prevalence of von Willebrand’s disease is approximately 1 case per 10,000 persons.[3] The actual abnormality (which does not necessarily lead to disease) occurs in 0.9-3% of the population. The symptoms of VWD is disproportionately more common in women of child-bearing age.[1] Although autosomal inheritance pattern of disease lead to an equal distribution of male patients and female patients, the disease has female predominance whose bleeding tendency shows during menstruation.[4][5] There is no racial predilection to vWD however, it may be more severe or apparent in people with blood type O.[6]
Epidemiology and Demographics
Prevalence
The prevalence of von Willebrand’s disease is 0.6 to 1.3%.[1][2] It is estimated that the referral prevalence of von Willebrand’s disease is approximately 1 case per 10,000 persons.[3]
The actual abnormality (which does not necessarily lead to disease) occurs in 0.9-3% of the population.
Age
The symptoms of VWD is disproportionately more common in women of child-bearing age.[1]
Gender
Although autosomal inheritance pattern of disease lead to an equal distribution of male patients and female patients, the disease has female predominance whose bleeding tendency shows during menstruation.[4][5]
Race
There is no racial predilection to vWD however, it may be more severe or apparent in people with blood type O.[6]
References
- ↑ 1.0 1.1 1.2 1.3 Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL; et al. (2008). "von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)". Haemophilia. 14 (2): 171–232. doi:10.1111/j.1365-2516.2007.01643.x. PMID 18315614.
- ↑ 2.0 2.1 Rodeghiero F, Castaman G, Dini E (1987). "Epidemiological investigation of the prevalence of von Willebrand's disease". Blood. 69 (2): 454–9. PMID 3492222.
- ↑ 3.0 3.1 Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D; et al. (2000). "Impact, diagnosis and treatment of von Willebrand disease". Thromb Haemost. 84 (2): 160–74. PMID 10959685.
- ↑ 4.0 4.1 Lee CA (1999). "Women and inherited bleeding disorders: menstrual issues". Semin Hematol. 36 (3 Suppl 4): 21–7. PMID 10513768.
- ↑ 5.0 5.1 Miller CH, Philipp CS, Stein SF, Kouides PA, Lukes AS, Heit JA; et al. (2011). "The spectrum of haemostatic characteristics of women with unexplained menorrhagia". Haemophilia. 17 (1): e223–9. doi:10.1111/j.1365-2516.2010.02382.x. PMID 21040234.
- ↑ 6.0 6.1 Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR (1987). "The effect of ABO blood group on the diagnosis of von Willebrand disease". Blood. 69 (6): 1691–5. PMID 3495304.